58
Participants
Start Date
November 16, 2017
Primary Completion Date
May 2, 2019
Study Completion Date
May 2, 2019
tDCS treatment
Participants visited the hospital four times (biweekly for two weeks). During their second visit, a research nurse instructed each participant on use of home-based tDCS equipment (YDS-301N; Ybrain Inc., Seongnam-si, Korea) and all participants thereafter conducted tDCS treatment at home once a day for 30 minutes (five times per week).
Antidepressant Drug(escitalopram)
Participants in both active and sham groups were prescribed escitalopram in combination with tDCS treatment.
Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul
Ybrain Inc.
INDUSTRY
Jeong-Ho Chae
OTHER